Compare THR & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | THR | FTRE |
|---|---|---|
| Founded | 1954 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.5M | 864.4M |
| IPO Year | 2011 | N/A |
| Metric | THR | FTRE |
|---|---|---|
| Price | $36.07 | $14.77 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $11.64 |
| AVG Volume (30 Days) | 301.7K | ★ 1.4M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.04 | N/A |
| EPS | ★ 1.75 | N/A |
| Revenue | $509,054,000.00 | ★ $2,759,900,000.00 |
| Revenue This Year | $2.56 | $3.17 |
| Revenue Next Year | $6.31 | $0.04 |
| P/E Ratio | $20.38 | ★ N/A |
| Revenue Growth | ★ 3.08 | 1.88 |
| 52 Week Low | $23.05 | $3.97 |
| 52 Week High | $36.14 | $25.05 |
| Indicator | THR | FTRE |
|---|---|---|
| Relative Strength Index (RSI) | 70.95 | 72.68 |
| Support Level | $34.70 | $12.12 |
| Resistance Level | $35.50 | $13.24 |
| Average True Range (ATR) | 1.09 | 0.97 |
| MACD | -0.04 | 0.31 |
| Stochastic Oscillator | 97.50 | 93.39 |
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.